| Market Capitalization (Millions $) |
313 |
| Shares
Outstanding (Millions) |
114 |
| Employees |
33 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-95 |
| Cash Flow (TTM) (Millions $) |
-2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Eledon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of various diseases and disorders. The company is dedicated to improving patients' lives through the discovery, development, and commercialization of advanced pharmaceutical products.
Eledon Pharmaceuticals specializes in the research and development of therapeutics in areas such as oncology, neurology, immunology, and cardiovascular diseases. They aim to address unmet medical needs by developing drugs that target specific mechanisms or pathways responsible for these conditions.
The company's team of scientists, researchers, and medical professionals work towards identifying potential drug candidates and conducting extensive preclinical and clinical trials. They collaborate with academic institutions, research organizations, and industry partners to accelerate the development process and bring innovative treatments to patients.
Eledon Pharmaceuticals Inc. places a strong emphasis on cutting-edge technology, novel drug delivery systems, and personalized medicine. They believe in the power of precision medicine and aim to develop therapies that are tailored to individual patients, offering improved efficacy and safety profiles.
Overall, Eledon Pharmaceuticals Inc. is dedicated to advancing the field of biopharmaceuticals by bringing transformative therapies to market that have the potential to significantly impact patients' quality of life.
Company Address: 19800 MacArthur Blvd Irvine 92612 CA
Company Phone Number: 238-8090 Stock Exchange / Ticker: NASDAQ ELDN
|
